Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics

E-ISSN： 1873-4286|16|9|1063-1080

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.9, 2010-03, pp. : 1063-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 29-38

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor 9 agonists as cancer therapeutics

By Holtick Udo Scheulen Max E von Bergwelt-Baildon Michael S Weihrauch Martin R

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 361-372

Informa Healthcare

Access to resources Recommend Favorite

Oxidised phospholipid regulation of Toll-like receptor signalling

By Erridge Clett Spickett Corinne M

Redox Report, Vol. 12, Iss. 1-2, 2007-02 ,pp. : 76-80

Maney Publishing

Access to resources Recommend Favorite

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 692-699

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Interactions in Interleukin and Toll-like Receptor Signaling Pathways

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1244-1258

Bentham Science Publishers

Access to resources Recommend Favorite